| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, U.s. Commercial | EVP, Head Of U.s. Commercial
1 company
Fox Christine serves as an EVP, U.s. Commercial at TEVA. Across recent SEC filings that breaks down to 0 buys and 8 sells. Those positions are worth an estimated $2.2M at current prices.
Historically, Fox Christine's trades have earned a below-average insider score of 23/100 across 5 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -80.8%.
The biggest single holding is TEVA (~$2.2M) as EVP, U.s. Commercial. The recent filings there lean toward selling, a net 122,078 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | TEVA Teva Pharmaceutical Industries Limited | EVP, U.s. Commercial | Sell | 21,258 | $35.31 | $750,619.98 | -25.0% | - | - | |
| Mar 5, 2026 | TEVA Teva Pharmaceutical Industries Limited | EVP, U.s. Commercial | Sale+OE | 7,924 | $31.67 | $250,940.40 | -8.5% | - | - | |
| Mar 4, 2026 | TEVA Teva Pharmaceutical Industries Limited | EVP, U.s. Commercial | Sale+OE | 9,098 | $32.46 | $295,362.02 | -10.8% | - | - | |
| Nov 20, 2025 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Head Of U.s. Commercial | Sale+OE | 28,229 | $24.78 | $699,523.09 | -30.7% | +40.5% | - | |
| Nov 14, 2025 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Head Of U.s. Commercial | Sell | 30,000 | $25.11 | $753,321.00 | -51.4% | +33.5% | - | |
| Mar 5, 2025 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Head Of U.s. Commercial | Sale+OE | 6,181 | $15.80 | $97,639.02 | -9.6% | +8.1% | +99.7% | |
| Nov 20, 2024 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Head Of U.s. Commercial | Sale+OE | 19,388 | $16.87 | $327,085.25 | -30.5% | -2.7% | +42.6% |